Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer - A study based on the EORTC trial 22881-10882 ‘boost versus no boost’: Collette S, Collette L, Budiharto T, et al (EORTC Headquarters, Brussels, Belgium; et al) Eur J Cancer 44:2587-2599, 2008 §